Contact this trialFirst, we need to learn more about you.
Monoclonal Antibodies
SPd vs EloPd Chemotherapy for Multiple Myeloma
Recruiting2 awardsPhase 3
Encinitas, California
This trial will compare two different chemotherapy regimens for multiple myeloma patients who have received one to four prior treatments. The first regimen contains the drugs pomalidomide, dexamethasone, and a monoclonal antibody. The second regimen contains the drugs elotuzumab, pomalidomide, and dexamethasone. The trial will measure efficacy, safety, and quality of life.
Fill-in a few details and create your profileSave answers to your profile & unlock recommendations.
We will keep your details privateWe won't share unless you give us permission. By completing this form you agree to our privacy policy and terms of service.
Get in touch with the study teamWe’ll send your responses to the study team and help you to setup your first screening. This is not the start of informed consent. Screening happens between you and the trial.
By clicking start, you agree to our
terms of service